Suraksha Diagnostic Limited

Suraksha Diagnostic Limited - healthcare in Kolkata, West Bengal, India. FY 2026 financials and compliance.
CIN L85110WB2005PLC102265 Incorporated 15 March 2005 ROC Kolkata HQ Kolkata, West Bengal, India
Active Listed Public Limited Company healthcare
Data last updated
Revenue · FY 2026
₹310.41 Cr
▲ 23.14% YoY
EBITDA · FY 2026
₹98.56 Cr
▲ 15.83% YoY
Net profit · FY 2026
₹31.4 Cr
▲ 1.37% YoY
Authorised capital
₹14 Cr
Registered with MCA
Paid-up capital
₹10.42 Cr
Issued & subscribed
Open charges
₹11.32 Cr
Satisfied ₹274.15 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
1,415
Latest available

About Suraksha Diagnostic Limited

Data last updated: 18 December 2025

Suraksha Diagnostic Limited is a public limited company based in Kolkata, West Bengal, India. It specialises in other hospital and medical care activities, a part of the broader healthcare sector. Incorporated on 15 March 2005, the company has been in operation for over 21 years.

Registered with ROC Kolkata under CIN L85110WB2005PLC102265. Listed.

Capital: an authorised share capital of ₹14 Cr and a paid-up capital of ₹10.42 Cr. It is led by directors including Satish Kumar Verma and Siddhartha Roy.

Last AGM: 05 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No Dg – 12/1 Action Area 1D Premises No 02 – 0327 New Town Rajarhat, Kolkata, West Bengal, India – 700156.

As per the financials filed for FY 2025, the company reported a revenue of ₹255.94 Cr, a growth of 15% compared to the previous year.

The company has a workforce of approximately 1,415 employees as per the latest available data. Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Suraksha Diagnostics. As per MCA filings, the company has open charges of ₹11.32 Cr and satisfied charges of ₹274.15 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website surakshanet.com.

Company Details of Suraksha Diagnostic Limited
CIN L85110WB2005PLC102265
Registration Number 102265
Incorporation Date 15 March 2005
ROC Kolkata
Listing Status Listed
Company Status Active
Date of Last AGM 05 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
  • Social Media
  • Apps
  • Registered Address
    Plot No Dg – 12/1 Action Area 1D Premises No 02 – 0327 New Town Rajarhat, Kolkata, West Bengal, India – 700156
  • Industry
    Healthcare, Other Hospital And Medical Care Activities
Company report
Suraksha Diagnostic Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Suraksha Diagnostic Limited report

Financials, compliance, directors, charges, ownership and filings for Suraksha Diagnostic Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has one previous CIN (Corporate Identification Number): U85110WB2005PTC102265. The current CIN is L85110WB2005PLC102265, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L85110WB2005PLC102265 Current
U85110WB2005PTC102265 Previous

Associated Brands with Suraksha Diagnostic Limited

Suraksha Diagnostic Limited operates one associated brand: Suraksha Diagnostics. These brands represent Suraksha Diagnostic Limited's diversified market presence and brand portfolio.

Brand Description Website
Pathology, molecular diagnostics, and imaging services are provided. surakshanet.com

Competitors & Alternatives of Suraksha Diagnostic Limited

Brands and companies operating in the same space as Suraksha Diagnostic Limited include Thyrocare, Krsnaa Diagnostics, Vijaya Diagnostic Centre and 6 more.

Competitor Description Location Founded
Thyrocare Thyrocare Diagnostic testing centers for pathology and health screenings are operated. Mumbai, India, India 1996
Krsnaa Diagnostics Krsnaa Diagnostics Chain of radiology & pathology laboratory centers Pune, India, India 2011
Vijaya Diagnostic Centre Vijaya Diagnostic Centre Diagnostic services are offered via a chain of centers. Hyderabad, India, India 1981
Igenetic Igenetic Provider molecular diagnostic solutions and services Mumbai, India, India 2013
PH Diagnostic Centre PH Diagnostic Centre Provider of medical diagnostic services including blood tests, urine tests, and specialized health check-ups Pune, India, India 2001
Health Ledger Health Ledger Chain of radiology & pathology laboratory centers Pune, India, India 2020
GD GD A chain of clinical laboratories is operated for diagnostic services. Mumbai, India, India 2007
Aarthi Scans Aarthi Scans Chain of diagnostic centers Chennai, India, India 2000
Medall Medall Medical diagnostic services are provided through a chain of centres. Chennai, India, India 2008

Business Activity of Suraksha Diagnostic Limited

Suraksha Diagnostic Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Q Hospital and Medical Care Q6 Other Hospital and Medical Care Activities *********

Auditor Details of Suraksha Diagnostic Limited

Suraksha Diagnostic Limited is audited by MSKA & ASSOCIATES LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
MSKA & ASSOCIATES LLP (ICAI peer reviewed, certificate valid till 2027-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Suraksha Diagnostic Limited

Suraksha Diagnostic Limited is currently managed by 9 directors, with 16 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Satish Kumar Verma Director 16 Jul 2024 1 Years 11 Months Current
Siddhartha Roy Director 03 Oct 2024 1 Years 9 Months Current
Somnath Chatterjee Managing Director 15 Mar 2005 21 Years 3 Months Current
Ishani Ray Director 16 Jul 2024 1 Years 11 Months Current
Ritu Mittal Managing Director 08 Nov 2006 19 Years 8 Months Current
Kanakayya Sathyamurthy Ravindra Cfo 01 Mar 2025 1 Years 4 Months Current
Showing 6 of 9 current directors. View all directors

Financials of Suraksha Diagnostic Limited FY 2026 filings available

Suraksha Diagnostic Limited reported revenue of ₹310.41 Cr (up 23.14% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹310.41 Cr ▲ 23.14%
Profit · FY 2026
₹31.4 Cr ▲ 1.37%
EBITDA · FY 2026
₹98.56 Cr ▲ 15.83%
Revenue₹ Cr · Consolidated0200400FY 2025: ₹252 Cr252FY 2025FY 2026: ₹310 Cr · +23.1% YoY310+23.1%FY 2026
Net Profit₹ Cr · Consolidated02040FY 2025: ₹31 Cr31FY 2025FY 2026: ₹31 Cr · +1.4% YoY31.4+1.4%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year050100Q2'25: ₹67 Cr66.8Q2'25Q3'25: ₹60 Cr59.5Q3'25Q4'25: ₹65 Cr65.1Q4'25Q1'26: ₹73 Cr72.6Q1'26Q2'26: ₹79 Cr · +17.9% YoY78.7+17.9%Q2'26Q3'26: ₹78 Cr · +30.5% YoY77.7+30.5%Q3'26Q4'26: ₹81 Cr · +25.1% YoY81.4+25.1%Q4'26
Metrics FY 2026 FY 2025
Revenue from Operations ₹310.41 Cr ₹252.09 Cr
Other Income ₹3.16 Cr ₹3.85 Cr
Total Income ₹313.58 Cr ₹255.94 Cr
Cost of Materials Consumed ₹36.48 Cr ₹29.52 Cr
Purchases of Stock-in-Trade ₹0 ₹0
Changes in Inventories ₹0 ₹0
Employee Benefit Expense ₹53.26 Cr ₹42.89 Cr
Finance Costs ₹12.55 Cr ₹8.39 Cr
Depreciation & Amortisation ₹41.45 Cr ₹35.3 Cr
Other Expenses ₹125.29 Cr ₹98.44 Cr
Total Expenses ₹269.02 Cr ₹214.53 Cr
Profit Before Exceptional Items & Tax ₹44.56 Cr ₹41.41 Cr
Exceptional Items ₹0 ₹0
Profit Before Tax ₹44.56 Cr ₹41.41 Cr
Total Tax Expense ₹13.15 Cr ₹10.43 Cr
Net Profit ₹31.4 Cr ₹30.98 Cr
  attributable to Owners ₹32.19 Cr ₹31.82 Cr
  attributable to NCI -₹78.46 Lakh -₹84.62 Lakh
Other Comprehensive Income ₹56.94 Lakh -₹20.39 Lakh
Total Comprehensive Income ₹31.97 Cr ₹30.77 Cr
EBITDA (computed) ₹98.56 Cr ₹85.09 Cr
Basic EPS ₹6.18 ₹5.97
Diluted EPS ₹6.18 ₹5.97
Metrics FY 2026 FY 2025
Total Assets ₹448.12 Cr ₹333.52 Cr
Non-current Assets ₹385.54 Cr ₹286.37 Cr
Current Assets ₹62.58 Cr ₹47.15 Cr
Property, Plant & Equipment ₹193.58 Cr ₹147.14 Cr
Inventories ₹8.14 Cr ₹8.05 Cr
Trade Receivables ₹22.76 Cr ₹13.81 Cr
Cash & Equivalents ₹3.21 Cr ₹2.25 Cr
Equity (Net Worth) ₹243.48 Cr ₹210.23 Cr
Equity Share Capital ₹10.42 Cr ₹10.42 Cr
Borrowings (Non-current) ₹17.76 Lakh ₹2.88 Cr
Borrowings (Current) ₹1.56 Cr ₹2.95 Cr
Total Debt (computed) ₹1.73 Cr ₹5.83 Cr
Current Liabilities ₹59.65 Cr ₹42.72 Cr
Total Liabilities ₹204.64 Cr ₹123.29 Cr
Metrics FY 2026 FY 2025
Operating Cash Flow ₹81.83 Cr ₹63.36 Cr
Investing Cash Flow -₹52.17 Cr -₹39.58 Cr
Financing Cash Flow -₹28.69 Cr -₹24.05 Cr
Capital Expenditure ₹67.34 Cr ₹42.02 Cr
Free Cash Flow (computed) ₹14.48 Cr ₹21.34 Cr
Dividends Paid ₹0 ₹0
Net Change in Cash ₹96.73 Lakh -₹27.32 Lakh
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25
Revenue from Operations ₹81.41 Cr ₹77.69 Cr ₹78.73 Cr ₹72.59 Cr ₹65.09 Cr ₹59.51 Cr ₹66.75 Cr
Other Income ₹78.54 Lakh ₹62.16 Lakh ₹85.14 Lakh ₹90.57 Lakh ₹81.68 Lakh ₹59.91 Lakh ₹1.31 Cr
Total Income ₹82.2 Cr ₹78.31 Cr ₹79.58 Cr ₹73.49 Cr ₹65.91 Cr ₹60.11 Cr ₹68.07 Cr
Cost of Materials Consumed ₹10.16 Cr ₹8.67 Cr ₹8.9 Cr ₹8.75 Cr ₹8.85 Cr ₹6.1 Cr ₹7.93 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹13.67 Cr ₹13.42 Cr ₹13.39 Cr ₹12.77 Cr ₹10.2 Cr ₹11.29 Cr ₹11.02 Cr
Finance Costs ₹3.92 Cr ₹3.16 Cr ₹2.78 Cr ₹2.7 Cr ₹2.06 Cr ₹1.98 Cr ₹2.13 Cr
Depreciation & Amortisation ₹11.26 Cr ₹10.56 Cr ₹10.14 Cr ₹9.48 Cr ₹8.73 Cr ₹8.83 Cr ₹8.75 Cr
Other Expenses ₹33.21 Cr ₹32.44 Cr ₹32.32 Cr ₹27.31 Cr ₹26.86 Cr ₹23.87 Cr ₹24.61 Cr
Total Expenses ₹72.22 Cr ₹68.25 Cr ₹67.53 Cr ₹61.02 Cr ₹56.7 Cr ₹52.07 Cr ₹54.43 Cr
Profit Before Exceptional Items & Tax ₹9.98 Cr ₹10.06 Cr ₹12.05 Cr ₹12.47 Cr ₹9.21 Cr ₹8.05 Cr ₹13.63 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹9.98 Cr ₹10.06 Cr ₹12.05 Cr ₹12.47 Cr ₹9.21 Cr ₹8.05 Cr ₹13.63 Cr
Total Tax Expense ₹3.82 Cr ₹2.82 Cr ₹3.22 Cr ₹3.29 Cr ₹2.04 Cr ₹2.06 Cr ₹3.48 Cr
Net Profit ₹6.16 Cr ₹7.24 Cr ₹8.83 Cr ₹9.18 Cr ₹7.17 Cr ₹5.98 Cr ₹10.16 Cr
  attributable to Owners ₹6.28 Cr ₹7.52 Cr ₹8.99 Cr ₹9.4 Cr ₹7.39 Cr - ₹10.34 Cr
  attributable to NCI -₹12.12 Lakh -₹28.24 Lakh -₹15.87 Lakh -₹22.23 Lakh -₹21.78 Lakh - -₹18.73 Lakh
Other Comprehensive Income ₹28.38 Lakh ₹9.52 Lakh -₹42,000 ₹19.46 Lakh -₹6.34 Lakh ₹12.24 Lakh ₹3.44 Lakh
Total Comprehensive Income ₹6.44 Cr ₹7.34 Cr ₹8.82 Cr ₹9.37 Cr ₹7.11 Cr ₹6.11 Cr ₹10.19 Cr
EBITDA (computed) ₹25.15 Cr ₹23.78 Cr ₹24.97 Cr ₹24.66 Cr ₹20 Cr ₹18.86 Cr ₹24.51 Cr
Basic EPS ₹1.21 ₹1.44 ₹1.73 ₹1.80 ₹1.42 ₹1.18 ₹1.94
Diluted EPS ₹1.21 ₹1.44 ₹1.73 ₹1.80 ₹1.42 ₹1.18 ₹1.94
Latest 7 quarters shown.
Metrics FY 2026 FY 2025
Revenue from Operations ₹300.68 Cr ₹249.1 Cr
Other Income ₹4.35 Cr ₹4.38 Cr
Total Income ₹305.03 Cr ₹253.48 Cr
Cost of Materials Consumed ₹36.1 Cr ₹28.95 Cr
Purchases of Stock-in-Trade ₹0 ₹0
Changes in Inventories ₹0 ₹0
Employee Benefit Expense ₹51.67 Cr ₹41.91 Cr
Finance Costs ₹12.34 Cr ₹8.39 Cr
Depreciation & Amortisation ₹39.6 Cr ₹34.73 Cr
Other Expenses ₹118.1 Cr ₹95.65 Cr
Total Expenses ₹257.82 Cr ₹209.62 Cr
Profit Before Exceptional Items & Tax ₹47.22 Cr ₹43.86 Cr
Exceptional Items ₹0 ₹0
Profit Before Tax ₹47.22 Cr ₹43.86 Cr
Total Tax Expense ₹13.15 Cr ₹10.42 Cr
Net Profit ₹34.06 Cr ₹33.44 Cr
Other Comprehensive Income ₹56.94 Lakh -₹20.39 Lakh
Total Comprehensive Income ₹34.63 Cr ₹33.24 Cr
EBITDA (computed) ₹99.16 Cr ₹86.97 Cr
Basic EPS ₹6.54 ₹6.42
Diluted EPS ₹6.54 ₹6.42
Metrics FY 2026 FY 2025
Total Assets ₹450.14 Cr ₹333.1 Cr
Non-current Assets ₹386.67 Cr ₹288.83 Cr
Current Assets ₹63.47 Cr ₹44.27 Cr
Property, Plant & Equipment ₹168.53 Cr ₹139.38 Cr
Inventories ₹8.12 Cr ₹8.02 Cr
Trade Receivables ₹24.86 Cr ₹15.06 Cr
Cash & Equivalents ₹2.3 Cr ₹1.48 Cr
Equity (Net Worth) ₹249.8 Cr ₹214.31 Cr
Equity Share Capital ₹10.42 Cr ₹10.42 Cr
Borrowings (Non-current) ₹13.2 Lakh ₹2.88 Cr
Borrowings (Current) ₹1.53 Cr ₹2.95 Cr
Total Debt (computed) ₹1.66 Cr ₹5.83 Cr
Current Liabilities ₹57.36 Cr ₹38.21 Cr
Total Liabilities ₹200.34 Cr ₹118.79 Cr
Metrics FY 2026 FY 2025
Operating Cash Flow ₹80.23 Cr ₹62.8 Cr
Investing Cash Flow -₹51.25 Cr -₹39.28 Cr
Financing Cash Flow -₹28.15 Cr ₹24.15 Cr
Capital Expenditure ₹50.12 Cr ₹35.39 Cr
Free Cash Flow (computed) ₹30.11 Cr ₹27.41 Cr
Dividends Paid ₹0 ₹0
Net Change in Cash ₹82.91 Lakh ₹47.66 Cr
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25
Revenue from Operations ₹78.56 Cr ₹75.58 Cr ₹76.26 Cr ₹70.28 Cr ₹64.15 Cr ₹58.57 Cr ₹65.95 Cr
Other Income ₹1.3 Cr ₹98.66 Lakh ₹96.72 Lakh ₹1.1 Cr ₹94.21 Lakh ₹97.45 Lakh ₹1.26 Cr
Total Income ₹79.86 Cr ₹76.57 Cr ₹77.23 Cr ₹71.37 Cr ₹65.09 Cr ₹59.54 Cr ₹67.2 Cr
Cost of Materials Consumed ₹10.03 Cr ₹8.58 Cr ₹8.8 Cr ₹8.69 Cr ₹8.59 Cr ₹5.99 Cr ₹7.83 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹13.23 Cr ₹13.03 Cr ₹12.99 Cr ₹12.41 Cr ₹10 Cr ₹11.01 Cr ₹10.71 Cr
Finance Costs ₹3.87 Cr ₹3.1 Cr ₹2.72 Cr ₹2.66 Cr ₹2.06 Cr ₹2.03 Cr ₹2.07 Cr
Depreciation & Amortisation ₹10.69 Cr ₹10.11 Cr ₹9.65 Cr ₹9.15 Cr ₹8.66 Cr ₹8.62 Cr ₹8.58 Cr
Other Expenses ₹31.49 Cr ₹30.78 Cr ₹30.5 Cr ₹25.34 Cr ₹25.74 Cr ₹23.47 Cr ₹23.84 Cr
Total Expenses ₹69.3 Cr ₹65.6 Cr ₹64.66 Cr ₹58.25 Cr ₹55.05 Cr ₹51.13 Cr ₹53.02 Cr
Profit Before Exceptional Items & Tax ₹10.56 Cr ₹10.97 Cr ₹12.57 Cr ₹13.12 Cr ₹10.04 Cr ₹8.42 Cr ₹14.18 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹10.56 Cr ₹10.97 Cr ₹12.57 Cr ₹13.12 Cr ₹10.04 Cr ₹8.42 Cr ₹14.18 Cr
Total Tax Expense ₹3.85 Cr ₹2.83 Cr ₹3.21 Cr ₹3.27 Cr ₹2.03 Cr ₹2.06 Cr ₹3.43 Cr
Net Profit ₹6.71 Cr ₹8.14 Cr ₹9.36 Cr ₹9.85 Cr ₹8.01 Cr ₹6.36 Cr ₹10.75 Cr
Other Comprehensive Income ₹28.38 Lakh ₹9.52 Lakh -₹42,000 ₹19.46 Lakh -₹6.34 Lakh ₹12.24 Lakh ₹3.44 Lakh
Total Comprehensive Income ₹6.99 Cr ₹8.24 Cr ₹9.36 Cr ₹10.04 Cr ₹7.94 Cr ₹6.48 Cr ₹10.78 Cr
EBITDA (computed) ₹25.11 Cr ₹24.18 Cr ₹24.94 Cr ₹24.93 Cr ₹20.76 Cr ₹19.07 Cr ₹24.83 Cr
Basic EPS ₹1.29 ₹1.56 ₹1.80 ₹1.89 ₹1.54 ₹1.22 ₹2.02
Diluted EPS ₹1.29 ₹1.56 ₹1.80 ₹1.89 ₹1.54 ₹1.22 ₹2.02
Latest 7 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Suraksha Diagnostic Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Suraksha Diagnostic Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 49.10%, foreign institutional investors hold 13.46%, domestic institutional investors hold 23.14%, retail and other public shareholders hold 14.31% of Suraksha Diagnostic Limited. The company had 67,107 shareholders on record.

Promoters: 49.10%DII (Domestic Institutional): 23.14%FII (Foreign Institutional): 13.46%Retail & Others: 14.31%
Mar 2026
QUARTER
49.10% Promoters
23.14% DII (Domestic Institutional)
13.46% FII (Foreign Institutional)
14.31% Retail & Others
Promoter holding - history
Now 49.10% · Mar 2026High 49.10% · Mar 2026Low 48.78% · Dec 2024
47%48%49%50%51%Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Dec 2024: 48.78%Mar 2025: 48.78%Jun 2025: 48.88%Sep 2025: 48.98%Dec 2025: 49.00%Mar 2026: 49.10%48.78%49.10%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters49.10%49.00%48.98%48.88%48.78%48.78%
Public50.90%51.00%51.02%51.12%51.22%51.22%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025
Promoters49.10%48.78%
Public50.90%51.22%
Promoter change (YoY, %pts)+0.32-

Board & Governance of Suraksha Diagnostic Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Suraksha Diagnostic Limited has 7 directors - 4 independent and 2 executive. The board is chaired by Dr. Somnath Chatterjee.

DirectorPositionOn board sinceListed boards
Dr. Somnath Chatterjee Executive Director · MD · Chairperson 2005-03-15 1
Ritu Mittal Executive Director · CEO-MD 2006-11-08 1
Satish Kumar Verma Non-Executive - Non Independent Director 2024-07-16 3
Pradip Kumar Dutta Non-Executive - Independent Director 2024-07-16 1
Ishani Ray Non-Executive - Independent Director 2024-07-16 4
Siddhartha Roy Non-Executive - Independent Director 2024-10-03 1
Dharam Chand Dharewa Non-Executive - Independent Director 2024-10-03 2
Board Committees
CommitteeMembers
Audit Committee Ishani Ray (Chairperson), Dharam Chand Dharewa, Ritu Mittal
Nomination and remuneration committee Ishani Ray (Chairperson), Pradip Kumar Dutta, Satish Kumar Verma, Siddhartha Roy
Stakeholders Relationship Committee Siddhartha Roy (Chairperson), Dr. Somnath Chatterjee, Ritu Mittal, Pradip Kumar Dutta
Corporate Social Responsibility Committee Dr. Somnath Chatterjee (Chairperson), Ritu Mittal, Dharam Chand Dharewa
Management and Finance Committee Dr. Somnath Chatterjee (Chairperson), Ritu Mittal, Dharam Chand Dharewa

Group Structure of Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has 1 subsidiary company. This group structure data is as of FY 2024. The corporate group structure reflects Suraksha Diagnostic Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Suraksha Radiology Private Limited U86905WB2023PTC265197 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Suraksha Diagnostic Limited

Open charges
₹11.32 Cr
Satisfied charges
₹274.15 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹10.72 Cr
Others₹0.60 Cr
Latest charge details
DateLenderAmountStatus
20 Feb 2025 Others ₹60 Lakh Open
15 May 2023 Hdfc Bank Limited ₹50 Lakh Open
28 Apr 2022 Hdfc Bank Limited ₹15 Lakh Open
26 Nov 2021 Hdfc Bank Limited ₹5.41 Cr Open
04 Oct 2021 Hdfc Bank Limited ₹2.65 Cr Open

Total charge records: 47 View all charges

Employees and EPFO Compliance at Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has a workforce of 1,415 employees as of Mar 24, 2024.

Employee count
1,415
Active EPFO establishments
1
Employee growth
-24.21%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Suraksha Diagnostic Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Suraksha Diagnostic Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Suraksha Diagnostic Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Suraksha Diagnostic Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Suraksha Diagnostic Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Suraksha Diagnostic Limited

MSME Payment Delays by Suraksha Diagnostic Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Suraksha Diagnostic Limited

Subsidiaries & Group Companies of Suraksha Diagnostic Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Suraksha Diagnostic Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Suraksha Diagnostic Limited

MCA Filings & Documents of Suraksha Diagnostic Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Suraksha Diagnostic Limited

Activity
05 Sep 2025
Suraksha Diagnostic Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records.
Charges
07 Aug 2025
A charge registered on 30 Oct 2019 via Charge ID 100308102 with Hdfc Bank Limited was fully satisfied on 07 Aug 2025.
Charges
15 Jul 2025
A charge registered on 18 Oct 2021 via Charge ID 100490832 with Others was fully satisfied on 15 Jul 2025.
Activity
31 Mar 2025
Suraksha Diagnostic Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Directors
01 Mar 2025
Kanakayya Sathyamurthy Ravindra was appointed as a CFO on 01 Mar 2025 & has been associated with this company since 1 year 4 months.
Charges
20 Feb 2025
A charge with Others amounted to Rs. 0.60 Cr with Charge ID 101066118 was registered on 20 Feb 2025.

Frequently Asked Questions about Suraksha Diagnostic Limited

Suraksha Diagnostic Limited is an active public limited company in the healthcare sector based in Kolkata, West Bengal, India. It was incorporated on 15 March 2005 (21+ years old) and is registered under CIN L85110WB2005PLC102265. The company has 1,415 employees.

Suraksha Diagnostic Limited reported revenue of ₹255.94 Cr for FY 2025 (up 15.00% YoY).

The current directors of Suraksha Diagnostic Limited are:

The primary industry of Suraksha Diagnostic Limited is healthcare. The company specifically operates in other hospital and medical care activities. The company is currently active in this sector.

Yes, Suraksha Diagnostic Limited is a listed company.

Suraksha Diagnostic Limited can be reached at the registered office: Plot No Dg – 121 Action Area 1D Premises No 02 – 0327 New Town Rajarhat, Kolkata, West Bengal, India – 700156, or through the website surakshanet.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available